Fiera Capital (Canada)
ONC

Fiera Capital (Canada)’s BeOne Medicines Ltd ONC Stock Holding History

Fiera Capital (Canada)’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.84M Buy
34,516
+734
+2% +$216K 0.04% 208
2026
Q1 		$10M Buy
33,782
+3,882
+13% +$1.26M 0.03% 220
2025
Q4 		$9.08M Buy
29,900
+4,783
+19% +$1.57M 0.03% 208
2025
Q3 		$8.56M Buy
25,117
+4,205
+20% +$1.28M 0.03% 207
2025
Q2 		$5.06M Buy
20,912
+6,748
+48% +$1.65M 0.02% 229
2025
Q1 		$3.86M Buy
14,164
+5,722
+68% +$1.34M 0.01% 243
2024
Q4 		$1.56M Buy
8,442
+2,431
+40% +$497K ﹤0.01% 319
2024
Q3 		$1.35M Buy
6,011
+2,275
+61% +$409K ﹤0.01% 330
2024
Q2 		$533K Buy
3,736
+1,176
+46% +$181K ﹤0.01% 375
2024
Q1 		$400K Sell
2,560
-5,820
-69% -$937K ﹤0.01% 424
2023
Q4 		$1.51M Sell
8,380
-200
-2% -$36.2K ﹤0.01% 326
2023
Q3 		$1.54M Buy
8,580
+231
+3% +$45.7K ﹤0.01% 316
2023
Q2 		$1.49M Sell
8,349
-188
-2% -$43.3K ﹤0.01% 317
2023
Q1 		$1.84M Buy
8,537
+266
+3% +$63.8K 0.01% 301
2022
Q4 		$1.82M Buy
8,271
+403
+5% +$73.9K 0.01% 300
2022
Q3 		$1.06M Hold
7,868
– – ﹤0.01% 373
2022
Q2 		$1.27M Hold
7,868
– – ﹤0.01% 368
2022
Q1 		$1.48M Sell
7,868
-132,515
-94% -$28.2M ﹤0.01% 372
2021
Q4 		$38M Sell
140,383
-4,856
-3% -$1.64M 0.09% 127
2021
Q3 		$52.7M Sell
145,239
-2,559
-2% -$837K 0.14% 92
2021
Q2 		$50.7M Sell
147,798
-3,503
-2% -$1.16M 0.13% 98
2021
Q1 		$52.7M Sell
151,301
-4,014
-3% -$1.33M 0.15% 85
2020
Q4 		$40.1M Buy
155,315
+601
+0.4% +$165K 0.11% 121
2020
Q3 		$44.3M Sell
154,714
-4,558
-3% -$1.07M 0.13% 96
2020
Q2 		$30M Sell
159,272
-5,290
-3% -$861K 0.1% 118
2020
Q1 		$20.3M Sell
164,562
-10,396
-6% -$1.63M 0.08% 149
2019
Q4 		$29M Sell
174,958
-16,992
-9% -$2.82M 0.1% 146
2019
Q3 		$23.5M Sell
191,950
-1,058
-0.5% -$141K 0.09% 158
2019
Q2 		$23.9M Sell
193,008
-13,154
-6% -$1.67M 0.09% 161
2019
Q1 		$27.2M Sell
206,162
-9,302
-4% -$1.26M 0.11% 151
2018
Q4 		$30.2M Buy
215,464
+209,568
+3,554% +$27.8M 0.14% 126
2018
Q3 		$1.01M Buy
+5,896
New +$992K ﹤0.01% 483

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Fiera Capital (Canada)'s ONC Position: Q2 2026 in Review

Fiera Capital (Canada) increased its BeOne Medicines Ltd (ONC) stake by 2.2% in Q2 2026, buying an estimated $216K and bringing the position to 34,516 shares worth $9.84M. The position accounts for 0.04% of the portfolio, ranked #208.

Fiera Capital (Canada) first reported a position in ONC in Q3 2018 and has held it in 32 quarters since. The position peaked at $52.7M in Q3 2021. 283 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Fiera Capital (Canada) held 34,516 shares of BeOne Medicines Ltd worth $9.84M as of Q2 2026.
  • Fiera Capital (Canada) bought 734 BeOne Medicines Ltd shares in Q2 2026, an estimated $216K.
  • BeOne Medicines Ltd made up 0.04% of Fiera Capital (Canada)'s portfolio in Q2 2026, its #208 holding.
  • Fiera Capital (Canada) first reported a position in BeOne Medicines Ltd in Q3 2018 and has held it in 32 quarters since.
  • Fiera Capital (Canada)'s BeOne Medicines Ltd position peaked at $52.7M in Q3 2021.
  • 283 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Fiera Capital (Canada)'s 13F filing for Q2 2026, filed 7 Aug 2026.